The Diagnostic Assessment Instruments Study Group was chaired by Jack D. Burke, Jr., M.D., M.P.H. The goal of the Assessment Instruments Study Group was to develop cross-cutting and disorder-specific dimensional assessments of severity for use in conjunction with the categorical diagnostic criteria.
The study group sought to develop instruments that are: useful for a broad range of professionals, such as psychiatrists, other mental health clinicians, primary care clinicians, and researchers; comparable across languages, cultures, and disorders; suitable in length, comprehension, and scoring. The study group members were also mindful of the need to develop instruments for specific populations, such as children and adolescents. The instruments developed by the study group were tested during the DSM-5 field trials.
Jack D. Burke Jr., M.D., M.P.H., Cambridge Health Alliance
Lee Anna Clark, Ph.D., University of Notre Dame
Bridget Grant, Ph.D., Ph.D., National Institute on Alcohol Abuse and Alcoholism
Helena C. Kraemer, Ph.D., Stanford University
William E. Narrow, M.D., M.P.H., American Psychiatric Association
David Shaffer, M.D., FRCP, Columbia University
Work Group Liaisons
Deanna M. Barch, Ph.D., Washington University in St. Louis
Arthur J. Barsky III, M.D.
Kathleen K. Bucholz, Ph.D., Washington University in St. Louis
Michelle Craske, Ph.D., University of California, Los Angeles
Raymond J. DePaulo, M.D.
Robert F. Krueger, Ph.D., University of Minnesota
Heino F. L. Meyer-Bahlburg, Dr., Rer. Nat
Joel Nigg, Ph.D., Oregon Health and Science University
Jane S. Paulsen, Ph.D., University of Iowa
Dieter Riemann, Ph.D., University Hospital of Freiburg
G. Terence Wilson, Ph.D.
Amy Wetherby, Ph.D., Florida State University
- Prudence Fisher, Ph.D.
Robert D. Gibbons, Ph.D.
John E. Helzer, M.D.
Kurt Kroenke, M.D., M.A.C.P.
Paul J. Pilkonis, Ph.D.